&w=3840&q=100)
On World IVF Day 2025, science and support reshape fertility journeys
These numbers not only reflect changing societal trends and health patterns, but also underline the growing demand for reproductive support systems such as in-vitro fertilisation (IVF) and other fertility treatment options.
Why is World IVF Day celebrated on 25 July?
World IVF Day is observed every year on 25 July, marking the birth of Louise Brown in 1978 — the world's first 'test-tube baby'. Her birth was a monumental milestone in medical science, achieved through the combined efforts of Dr Robert Geoffrey Edwards, Dr Patrick Christopher Steptoe and nurse Jean Marian Purdy.
Dr Edwards was awarded the 2010 Nobel Prize for his work in developing IVF.
Why World IVF Day is also Embryologist Day
World IVF Day is also celebrated as World Embryologist Day to recognise and honour the contributions that embryologists have made to the field of medicine and reproductive health. Embryologists are highly trained scientists who handle eggs, sperm, and embryos in the lab, ensuring they are carefully monitored and developed before implantation. Without embryologists, the complex and delicate procedures involved in IVF would not be possible.
What is IVF and who is it for?
In-vitro fertilisation (IVF) is a medical process in which an egg is fertilised by sperm outside the body, and then implanted into the uterus. It is often used when other fertility treatments have failed, or in cases of unexplained infertility, advanced maternal age, genetic concerns, or certain health conditions in either partner.
According to a 2022 report by Ernst and Young, there were around 2–2.5 lakh IVF cycles performed yearly in India. The report says that the Indian fertility industry is expected to reach $1,453 million by 2027 with the potential to carry out 5–6 lakh IVF cycles annually.
The aim of IVF Day: Science, support, and awareness
This day aims to highlight the breakthroughs in assisted reproductive technology and aims to:
Raise awareness of infertility and available treatments
Recognise scientific achievements in reproductive medicine
Appreciate the emotional and physical journey of patients undergoing fertility treatments
Celebrate the professionals, especially embryologists
Why IVF awareness matters more than ever in India
According to the State of World Population Report 2025 released by the United Nations Population Fund (UNFPA), India's total fertility rate (TFR) has now dropped to 2.0, slipping below the replacement level of 2.1. As fertility challenges become more common due to lifestyle changes, delayed parenthood, and health factors, awareness campaigns about alternative options serve an important purpose. They not only educate people about options like IVF, but also normalise seeking help and embracing science when needed. For more health updates, follow #HealthWithBS
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
33 minutes ago
- The Hindu
Pakistani Hindu doctor, stateless for four years, gets Indian citizenship
A doctor from Pakistan, 'stateless' for the past four years, has been registered as an Indian citizen, the Gujarat High Court was informed on Thursday (August 7, 2025). Nanikraz Khanoomal Mukhi (53), who had a sonography clinic in Pakistan's Hyderabad, chose to move to India in 2009 for his children's education and to escape possible religious persecution. Dr. Mukhi was registered as an Indian on August 5 under Section 5 (1) (A) of the Citizenship Act, 1955 by the office of District Magistrate, Ahmedabad. The Section prescribes citizenship to a person of Indian origin who is ordinarily resident in India for seven years before making an application for registration and is not an illegal migrant. The Hindu reported about Dr. Mukhi's case on July 19. Dr. Mukhi had been running from pillar to post to get registered as an Indian since 2021, when he renounced his Pakistani passport after receiving a letter from the Ahmedabad Collector's office that the application has been processed and he would receive the citizenship soon. He applied for citizenship in 2016. Clinic sealed As his application remained stuck in red tape, his clinic in Ahmedabad was sealed by the health officials as he was not an Indian citizen. Dr. Mukhi moved the Gujarat High Court against the Union of India and the State of Gujarat on April 30. After the Union government's counsel informed the court on Thursday that Dr. Mukhi has been granted citizenship, he decided to withdraw the petition. 'As an Indian I will get legal rights and the right to practice as a medical doctor now. I can apply for a voter card and a passport. I did not have any rights for the past four years. I had no nationality so far. It is a huge relief,' Dr. Mukhi told The Hindu. He added that he would apply for a medical licence with the Gujarat Medical Council soon. Dr. Mukhi's wife, who had applied for citizenship with him, has been granted the naturalisation certificate. His three children acquired citizenship after they registered under the Citizenship Amendment Act (CAA), 2019, which became effective on March 11, 2024. Citizenship is a subject under the Union List and is decided by the Ministry of Home Affairs. The MHA has delegated powers to district magistrates/collectors of 31 districts in nine States, including Gujarat, to grant citizenship to legal migrants (who entered on passport/visa) from the Hindu, Sikh, Buddhist, Jain, Parsi and Christian communities from Pakistan, Bangladesh and Afghanistan under Section 5 (by registration) and Section 6 (naturalisation) of the Citizenship Act, 1955.
New Indian Express
an hour ago
- New Indian Express
Urgently scale-up research and innovation to end TB: WHO
NEW DELHI: The World Health Organisation (WHO) has called for an urgent scale-up of research, innovation, and collaboration to accelerate momentum towards ending tuberculosis in the WHO South-East Asia Region, which continues to bear nearly half of the global TB burden, accounting for the highest share of cases and deaths worldwide. 'In our Region alone, nearly 5 million people developed TB and close to 600,000 died from the disease in 2023,' said Dr Catharina Boehme, Officer-in-Charge, WHO South-East Asia Region. Calling for urgent action, she said, 'Achieving the ambitious targets in the WHO End TB Strategy requires collaboration to accelerate research and innovation. It requires the adoption and use of new tools, technologies, and drugs. Ensuring timely and equitable access to these innovations remains critical to achieving impacts at scale, leaving no one behind.' While the Region, which includes India, recorded a significant increase in TB case notifications in 2023 - signalling recovery after COVID-19-related setbacks - progress remains insufficient to meet the End TB Strategy targets aligned with the Sustainable Development Goals, which call for a 90 per cent reduction in TB deaths and an 80 per cent reduction in incidence by 2030, compared to 2015 levels. India aims to eliminate TB by 2025, ahead of the global target.
Mint
an hour ago
- Mint
Acko ramps up health insurance play to expand healthcare reach
BENGALURU : Nearly a year after acquiring Better Capital-backed chronic-care startup OneCare, insurtech Acko Technology and Services Pvt. Ltd is doubling down on health insurance offerings, expanding partnerships with hospitals and clinics to tap into the growing opportunity in the space, a top executive told Mint. The Bengaluru-based unicorn acquired the digital chronic-care management company in an all-cash deal in 2024 to enter the health insurance segment. The firm, which began with auto insurance in 2016, is now working on integrating the entire process of buying health insurance—from picking a lab for medical testing to interacting with a hospital for claims. 'The problem in the health insurance industry today is that the burden of the entire process is on the customer. If there's a breakdown in the system, they're on their own. We're working towards integrating the entire system on our app and actually hand-holding customers to pick the best testing labs and hospitals," Animesh Das, managing director and chief executive of Acko General Insurance, told Mint in an interview. Acko aims to capitalize on the booming Indian healthcare sector, which is valued at over $372 billion and is growing at a compound annual growth rate of 21% since 2014, according to estimates by government think tank Niti Aayog. With health premiums already accounting for more than half of Acko's overall premium income, the firm has invested substantially to grow the segment over the last year, Das said. Acko has secured nearly $450 million in funding from investors, including Multiples PE, Accel, Elevation Capital, and General Atlantic. It was last valued at $1.1 billion in October 2021. Last week, cricketer M.S. Dhoni announced his investment in the firm and hopped on board as its brand ambassador. In the healthcare sector, Acko is in direct competition with players such as PharmEasy, HealthQuad-backed HealthifyMe, and HealthPlix that provide healthcare services such as diagnostic tests and doctor consultations. Motor insurance slowdown While Acko is yet to officially file its 2024-25 financials with the Registrar of Companies (RoC), it witnessed 'measured growth" during the year. 'It was a year of learning to know what levers will drive growth for us. Doubling down on health is a product of that learning," Das said. 'Healthcare services are a long-term game for us." The integration of its various insurance services will also result in customers engaging with the platform more regularly, which otherwise tends to be an annual activity. In the fiscal year ended March 2024, Acko's revenue climbed to ₹2,106 crore from ₹1,758 crore in the year prior, filings available with the RoC showed. Its losses narrowed marginally to ₹670 crore from ₹738 crore. Acko is among venture capital firm Elevation Capital's portfolio companies looking to get publicly listed soon. Mint reported on 6 August that the VC firm plans to take at least nine portfolio companies public over the next 12-24 months, as it gears up to monetize its portfolio amid improving public market conditions for tech and consumer startups in the country. Das declined to comment on the IPO timeline. Acko is evolving its model to keep up with a slowdown in the industry. The firm has struck a partnership with American carmaker Tesla Inc. as the insurance partner in India. 'Tesla's branding of a new-age automaker designed for young and aspirational buyers ties in well with the shift in consumer cohorts in our insurance products," Das said. A July Nuvama report said the insurance industry in India is slowing primarily due to moderation in auto sales and a drop in corporate renewal policies. Motor insurance growth has slowed down due to weak retail motor sales. The gross direct premium income (GDPI) in the motor segment rose 6.7% in June 2025, compared to 8.2% in the year-ago period.
